ProFound AI for Digital Breast Tomosynthesis

iCAD

The concurrent-read, cancer detection and workflow solution from iCAD analyzes each tomosynthesis image, detecting both malignant soft tissue densities and calcifications.
Built on deep-learning and artificial intelligence technology, ProFound AI for breast tomosynthesis assists radiologists in addressing the challenges of reading tomosynthesis.

Formerly branded as PowerLook Tomo Detection 2.0
Product specifications Information source: Public
Last updated: Jan. 10, 2020
General
Product name ProFound AI for Digital Breast Tomosynthesis
Company iCAD
Subspeciality Breast
Modality Mammography
Disease targeted breast cancer
Key-features malignancy detection, calcification detection, certainty scoring, case scoring
Suggested use
Data characteristics
Population
Input
Input format
Output
Output format
Technology
Integration
Deployment
Trigger for analysis
Processing time
Certification
CE Certified, class unknown
FDA 510(k) cleared, class unknown
Market presence
On market since
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers